Mobile health-technology integrated care in atrial fibrillation patients with heart failure: A report from the mAFA-II randomized clinical trial

CONCLUSION: A mHealth-technology implemented ABC pathway provides consistent effects on the risks of primary outcome, rehospitalisation and bleeding, in AF patients both with and without HF. However, AF-HF patients may need tailored approaches to improve their overall prognosis, specifically to reduce the risk of recurrent AF, HF and acute coronary syndrome.PMID:36347740 | DOI:10.1016/j.ejim.2022.11.002

Source: European Journal of Internal Medicine - November 8, 2022 Category: Internal Medicine Authors: Yutao Guo Giulio Francesco Romiti Bernadette Corica Marco Proietti Niccol ò Bonini Hui Zhang Gregory Yh Lip mAF-App II trial investigators Source Type: research